Global Veterinary CRO and CDMO Market Size & Trends Report Segmented by Product (Small Molecules, Biologics, Nutraceuticals, Medical Devices), Animal Type (Companion, Livestock), Therapeutic Area (Infections, Oncology), Phase (Pre-clinical, Clinical, Commercial) Regional Forecast to 2030

Request Quote Download FREE Sample
Single User
The global veterinary CRO and CDMO market is set to witness a growth rate of 9% in the next 5 years. Rapid growth in companion-animal healthcare spending, rise of complex modalities, growing pressure to shorten time-to-market & control R&D costs, and growing consolidation & preference for platform service models, are some of the key factors driving the veterinary CRO and CDMO market. To learn more about the research report, download a sample report.

Overview

Veterinary contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs) offer a unique service model that aids animal health organizations in the development, testing, and ultimately manufacture of veterinary medicines, vaccines, and biologics among others. CROs are responsible for research elements, e.g., preclinical studies, safety studies, clinical trials and ensuring regulatory compliance; while a CDMO supports the formulation, process and product development, scale-up, and GMP manufacturing. Veterinary CROs and CDMOs support animal health companies in overcoming issues pertaining to expertise, infrastructure, and cost showing an overall benefit through shortened time to market and allowing animal health companies to focus on their core strategic goals.

Veterinary CRO and CDMO Market

To learn more about this report, download the PDF brochure

Rapid growth in companion-animal healthcare spending to drive market growth

The veterinary CRO and CDMO market is heavily influenced by the surge in companion-animal healthcare spending because pet owners are increasingly looking for more advanced therapies (biologics, oncology and specialty medicines). In the US alone, total expenditure on pets (i.e., pet industry) increased substantially by c.46% between 2020-2024e. Expenditure on pet health & products increased c.25% between 2020-2024e (Source: APPA). As disposable incomes rise, and emotional bonds between pets and their owners strengthen, consumers are more willing to spend money for the absolute best care for their companion animals. This requires animal health companies to build pipelines and to leverage outsourcing services (to CROs and CDMOs) for preclinical studies, research and development, clinical testing for new molecular entities, and manufacturing. All this bodes well for faster times to market, increased services needed, and continued growth in the market at a global level.

Veterinary CRO and CDMO Market - Segmentation

To learn more about this report, download the PDF brochure

Growing consolidation & preference for platform service to boost market growth

Increasing consolidation & preference for platform services is driving growth in the veterinary CRO and CDMO markets by offering integrated, end-to-end solutions that more effectively facilitate the development and manufacture of products. Instead of working with multiple organizations with distinct services, animal health clients increasingly prefer to partner with service providers that can offer everything from discovery and toxicology to clinical trials and regulatory and commercial-scale production under one umbrella. This reduces the complexity of managing various timelines, expands potential efficiencies, and improves cost effectiveness. Consolidation through M&A also expands global reach and capabilities, enabling service providers to offer comprehensive platforms that attract more clients and drive sustained market expansion.

Competitive Landscape Analysis

The global veterinary CRO and CDMO market is marked by the presence of established and emerging market players such as Charles River Laboratories; Clinglobal; Argenta Holdco Limited; knoell Germany GmbH; OCRvet; Veterinary Research Management; VETSPIN SRL; Vetio; TriRx Pharmaceutical Services; and Tekrolab; among others. Some of the key strategies adopted by market players include new service launch, strategic partnerships and collaborations, and geographic expansion.

Report Scope

Report Metric Details
Base Year Considered 2024
Historical Data 2023 - 2024
Forecast Period 2025 - 2030
Growth Rate 9%
Market Drivers
  • Rapid growth in companion-animal healthcare spending
  • Rise of complex modalities
  • Growing pressure to shorten time-to-market & control R&D costs
  • Growing consolidation & preference for platform service models
Attractive Opportunities
  • Biologics, monoclonal antibodies and novel vaccines
  • Geographic expansion and local manufacturing in emerging markets
  • Platform and verticalized/end-to-end service offerings
  • Data services and real-world evidence
Segment Scope By Product, Animal Type, Therapeutic Area, Phase, End User
Regional Scope
  • North America (US & Canada)
  • Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
  • Asia Pacific (China, India, Japan, Rest of Asia Pacific)
  • Latin America
  • Middle East & Africa
Key Companies Mapped Charles River Laboratories; Clinglobal; Argenta Holdco Limited; knoell Germany GmbH; OCRvet; Veterinary Research Management; VETSPIN SRL; Vetio; TriRx Pharmaceutical Services; and Tekrolab among others
Report Highlights Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis

Global Veterinary CRO and CDMO Market Segmentation

This report by Medi-Tech Insights provides thesize of the global veterinary CRO and CDMO market at theregional- and country-level from 2023 to 2030. The report further segments the market based on product, animal type, therapeutic area, phase, and end user.

Market Size & Forecast (2023-2030), By Product, USD Million

  • Small Molecules
  • Biologics
  • Nutraceuticals and Feed Additives
  • Medical Devices

Market Size & Forecast (2023-2030), By Animal Type, USD Million

  • Companion Animals
  • Livestock Animals

Market Size & Forecast (2023-2030), By Therapeutic Area, USD Million

  • Infectious Diseases
  • Oncology
  • Dermatology
  • Pain & Inflammation Management
  • Disorders
  • Others

Market Size & Forecast (2023-2030), By Phase, USD Million

  • Pre-clinical
  • Clinical
  • Commercial

Market Size & Forecast (2023-2030), By End User, USD Million

  • Veterinary Pharmaceutical and Biopharmaceutical Companies
  • Veterinary Medical Device Companies
  • Others

Market Size & Forecast (2023-2030), By Region, USD Million

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

Key Strategic Questions Addressed

  • What is the market size & forecast of the veterinary CRO and CDMO market?
  • What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the veterinary CRO and CDMO market?
  • What are the key trends defining the market?
  • What are the major factors impacting the market?
  • What are the opportunities prevailing in the market?
  • Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
  • Who are the major players operating in the market?
  • What are the key strategies adopted by players?

Related Reports

Need a More Tailored Analysis?

  • Discuss the market sizing methodology and forecast assumptions with our healthcare analysts.
  • Expand the scope with additional countries, market segments, technologies, or competitor profiling.
  • Use the insights to support strategic planning, market entry, commercial due diligence, and long-term revenue growth initiatives.
Request a FREE Sample